An Important Proportion of Genital Samples Submitted for Chlamydia trachomatis Detection by PCR Contain Small Amounts of Cellular DNA as Measured by β-Globin Gene Amplification

ABSTRACT We assessed the quality of genital samples submitted forChlamydia trachomatis detection by PCR by a second PCR assay for the presence of human β-globin DNA. Endocervical and urethral samples were first tested by the COBAS AMPLICOR C. trachomatis assay (Roche Diagnostic Systems) with an internal control and were then amplified for the presence of β-globin DNA with primers PC04 and GH20. Samples that contained inhibitors were retested after dilution 1:10. A total of 407 genital samples (311 endocervical swabs from 311 women and 96 urethral swabs from 95 men and 1 woman) collected over a 1-month period were evaluated. The internal control could not be amplified, despite dilution, from 3 of 23 samples that were retested after dilution because of inhibition, leaving 404 samples that could be analyzed by PCR. Eleven samples tested positive forC. trachomatis. Thirty (7.4%) of the 404 samples were negative for β-globin. Twelve of the 23 undiluted samples that contained inhibitors tested positive for β-globin DNA. Amplification of β-globin DNA in samples submitted for C. trachomatisdetection by the COBAS AMPLICOR C. trachomatis assay demonstrated that an important proportion of the samples did not contain cellular DNA. Assessment of the quality of the samples for PCR analysis by β-globin amplification is feasible but cannot replace use of the internal control.

[1]  E. Franco,et al.  Nonisotopic Detection and Typing of Human Papillomavirus DNA in Genital Samples by the Line Blot Assay , 1999, Journal of Clinical Microbiology.

[2]  J. Vincelette,et al.  Multicenter Evaluation of the Fully Automated COBAS AMPLICOR PCR Test for Detection of Chlamydia trachomatis in Urogenital Specimens , 1999, Journal of Clinical Microbiology.

[3]  J. Sellors,et al.  Urine Specimens from Pregnant and Nonpregnant Women Inhibitory to Amplification of Chlamydia trachomatis Nucleic Acid by PCR, Ligase Chain Reaction, and Transcription-Mediated Amplification: Identification of Urinary Substances Associated with Inhibition and Removal of Inhibitory Activity , 1998, Journal of Clinical Microbiology.

[4]  C. Peyton,et al.  Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method , 1998, Journal of Clinical Microbiology.

[5]  K. Ramotar,et al.  Inhibition of PCR in Genital and Urine Specimens Submitted for Chlamydia trachomatis Testing , 1998, Journal of Clinical Microbiology.

[6]  C. Black,et al.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections. , 1998, Clinical microbiology reviews.

[7]  Maurice Rosenstraus,et al.  An Internal Control for Routine Diagnostic PCR: Design, Properties, and Effect on Clinical Performance , 1998, Journal of Clinical Microbiology.

[8]  T. Quinn,et al.  Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections , 1997, Journal of clinical microbiology.

[9]  F. Coutlée,et al.  Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction , 1997, Journal of medical virology.

[10]  H. Verbrugh,et al.  Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay , 1996, Journal of clinical microbiology.

[11]  J. Kellogg Impact of variation in endocervical specimen collection and testing techniques on frequency of false-positive and false-negative Chlamydia detection results. , 1995, American journal of clinical pathology.

[12]  J. Kellogg,et al.  Improved PCR detection of Chlamydia trachomatis by using an altered method of specimen transport and high-quality endocervical specimens , 1995, Journal of clinical microbiology.

[13]  A K Highsmith,et al.  Surveillance for waterborne disease outbreaks--United States, 1991-1992. , 1993, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[14]  H. Eichenwald Hepatitis E among U.S. travelers, 1989-1992. , 1993, MMWR. Morbidity and mortality weekly report.

[15]  J. Underwood Diagnostic Molecular Pathology. A Practical Approach , 1993 .

[16]  A. Reingold,et al.  Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.

[17]  H. Fox,et al.  Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. , 1990, Journal of the National Cancer Institute.

[18]  C. L. Murray,et al.  Effect of endocervical specimen quality on detection of Chlamydia trachomatis and on the incidence of false-positive results with the Chlamydiazyme method , 1990, Journal of clinical microbiology.

[19]  M. Aronson,et al.  Use of a direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecologic care. , 1987, The Journal of infectious diseases.

[20]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[21]  D. Persing,et al.  Diagnostic molecular microbiology. , 2001, Current clinical topics in infectious diseases.

[22]  G. Schmid,et al.  Recommendations for the Prevention and Management of Chlamydia trachomatis Infections , 1993 , 1994 .